• Episode: 67 - Anthony Tolcher Discusses Oncology, Dual-Payload Technology, and the ADC Field

  • 2024/11/12
  • 再生時間： 43 分
  • ポッドキャスト

Episode: 67 - Anthony Tolcher Discusses Oncology, Dual-Payload Technology, and the ADC Field

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • November 12, 2024 | In this episode of The Chain, host Rakesh Dixit, PhD, DABT, president and founder of Bionavigen Oncology and Regio Biosciences, speaks with Anthony Tolcher, M.D., FRCPC, cofounder of NEXT Oncology, about antibody drug conjugates (ADCs) including the role of the bystander effect, approaching targets in oncology, dual-payload technologies, the potency of new payloads, and bispecific targeting. Tolcher also shares what inspired him to pursue oncology, how he came across ADCs, and where he sees ADCs heading in the future.

    LINKS:
    Bionavigen
    NEXT Oncology

    続きを読む 一部表示

あらすじ・解説

November 12, 2024 | In this episode of The Chain, host Rakesh Dixit, PhD, DABT, president and founder of Bionavigen Oncology and Regio Biosciences, speaks with Anthony Tolcher, M.D., FRCPC, cofounder of NEXT Oncology, about antibody drug conjugates (ADCs) including the role of the bystander effect, approaching targets in oncology, dual-payload technologies, the potency of new payloads, and bispecific targeting. Tolcher also shares what inspired him to pursue oncology, how he came across ADCs, and where he sees ADCs heading in the future.

LINKS:
Bionavigen
NEXT Oncology

続きを読む 一部表示

Episode: 67 - Anthony Tolcher Discusses Oncology, Dual-Payload Technology, and the ADC Fieldに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。